Fungi pose a greater threat to plant and animal biodiversity than other types of pathogens (protists, viruses, bacteria, helminths), and the threat of fungi to ourselves, our food security, and our environment is increasing (Fischer et al., Nature 484:186-194 (2012)). Human diseases caused by fungi (mycoses) are on the rise concomitantly with the increase in numbers of people with immunosuppressive conditions (i.e. AIDS, organ transplants, cancer treatments). Infections of immunocompromised humans by fungi including Aspergillus fumigatus and Cryptococcus neoformans have increased due to their ability, which is fairly unique among fungi, to grow at body temperatures. Acquired drug resistance in medically relevant microorganisms, including fungi and bacteria, is another severe threat to human health. In addition, fungi and fungal-like organisms are responsible for the destruction of about 125 million tons of major crops such as rice, wheat, maize, potatoes, and soybeans each year.
History also shows that fungi and fungal-like organisms can dramatically affect human health and food security. For example, the Irish Potato Famine, which was caused by the late blight mold, resulted in mass starvation, and the death of 1 million people in the 1840s. More recently, a new strain of wheat rust from Africa, UG99 (Uganda 99), which causes up to 100% crop loss, is spreading across wheat growing regions of the world. Mycotoxins pose a threat to human health on nearly every continent, and climate change is shifting their appearance to new areas (Magan et al., Plant Pathology 60:150-163 (2011)).
Among mycotoxin contamination of crops, one of the most serious is aflatoxin contamination of crops. Aflatoxin is thought to be the most potent naturally occurring carcinogen known. An aflatoxin contaminated diet has been directly linked with elevated rates of liver cancer, decreased immunity, kwashiorkor, and growth stunting.
In western countries, amounts of aflatoxin contaminants in crops are regulated to below 10 parts per billion. However, outbreaks of aflatoxicosis are common in underdeveloped countries, mostly among poorly nourished rural populations whose staple food is maize. Large losses of crops contaminated with aflatoxin are common. Worldwide, Aspergillus species cause significant losses in major crops. The annual economic impact of aflatoxin contamination on corn and peanut agriculture in the United States is thought to exceed $1 billion dollars.
A second major class of mycotoxins is the trichothecenes, including T-2 toxin, nivalenol, deoxynivalenol, and diacetoxyscirpenol, produced by the fungi Fusarium, Cephalosporium, Myrothecium, Stachybotrys (the black mold), Trichoderma, and others. In western countries, levels of deoxynivalenol are advised to be less than 1 ppm for finished grain products for human consumption. The trichothecenes are also damaging to the health of pigs, cattle, poultry, and particularly swine. Due to climate change and global warming in recent years, mycotoxigenic fungi are altering their ranges, moving into areas in which they were not previously found.
Described herein are methods that include extracting lichens and testing the extracts so obtained for their effects on fungal sporulation, fungal hyphal growth and fungal secondary metabolite production. Also described are anti-fungal compositions, as well as methods for determining the microbial source and the structure of the active compounds.
One method involves extracting a lichen sample with alcohol, ethyl acetate, acetone or a combination thereof to provide a lichen extract, and measuring whether the lichen extract inhibits the growth, sporulation, or mycotoxin production of a fungus.
Another method involves (a) extracting a lichen sample with alcohol, ethyl acetate, acetone or a combination thereof to provide a lichen extract; (b) mixing the extract, a component of the extract, or a compound obtained from the extract with Aspergillus parasiticus strain B62 cells to form an assay mixture; and (c) measuring whether growth, sporulation, or aflatoxin production by the Aspergillus parasiticus strain B62 cells is different from a control.
Another method involves extracting a lichen as in (a) described above, and (h) mixing the extract, a component of the extract, or a compound obtained from the extract with Fusarium graminearum to form an assay mixture; and (c) measuring whether growth or deoxynivalenol or 15-acetyl deoxynivalenol or nivalenol production of variations thereof by the Fusarium graminearum cells is different from a control.
The methods can be used to provide useful lichen extracts, compounds, or components of the extracts.
Compositions are also described herein that can include a carrier and an extract, compound, or a component of an extract obtained, for example, by the methods described herein.
Such compositions, extracts, compounds, and extract components are useful for inhibiting fungal growth, fungal sporulation, toxin production, or a combination thereof. For example, the compositions, extracts, compounds, and extract components can reduce mycotoxin or toxin production by at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70% at least 80%, at least 90%, at least 95%, or at least 99%.
The extracts are stable, and retain the ability to inhibit fungal growth, fungal sporulation, fungal toxin production, or a combination thereof for at least ten years, or at least 20 years, or at least 30 years.
The compositions, extracts, compounds, and extract components can be applied to structures, surfaces, agricultural crops, storage bins, storage facilities, animal feed, plant seeds, nuts, plant parts, plant products, or a combination thereof. The compositions, extracts, compounds, and extract components can be applied to surfaces in bathrooms, kitchens, closets, basements, attics, entryways, cabinets, boats, hams, animal shelters, warehouses, food storage facilities, and other such surfaces. The compositions, extracts, compounds, and extract components can be applied to grain-producing plants, nut-producing plants, vegetable-producing plants, fruit-producing plants, starch-producing plants, fiber-producing plants, fodder-producing plants, grains, nuts, vegetables, fruits, starch, fibers, flour, fodder, leaves, stock, seeds, oil, or a combination thereof. The compositions, extracts, compounds, and extract components can be applied to almonds, barky, betel nuts, brazil nuts, cashews, chestnuts, coconut, coffee, corn, flour, hazelnuts, macadamia nuts, oats, pecans, peanuts, pine nuts, pistachios, rice, rye, sesame seeds, soybean, spices, walnuts, wheat, or combinations thereof.
Such methods can reduce the mycotoxin, fungal spore, or fungal content in the surfaces, agricultural crops, storage bins, storage facilities, animal feeds, plant seeds, nuts, plant parts, plant products, or other places.
As described herein, lichens can produce a plethora of unique secondary compounds, which are useful in medical, agricultural and food safety applications. Lichens exhibit significant longevity and robustness despite a close association with diverse microbes and harsh environmental conditions. Lichens provide model organisms for identifying and evaluating compounds that can be useful as anti-fungal agents. As described herein, extracts from lichen species were prepared, their activities were tested, and useful compounds have been identified and isolated.
Lichens
Lichens are some of the longest-living organisms known. Despite their slow growth, they very rarely appear die of disease. The lichenized fungus establishes the main lichen thallus in association with an alga or cyanobacterium, and has been recently shown, a basidiomycete yeast is widely included (Spribille et al. Science 3S3: 488-492 (2006)). This scaffold becomes a niche for a variety of other filamentous ascomycetes and basidiomycetes, yeasts, bacteria, and occasionally insects.
Lichens are defined by symbiotic interactions between a fungus and photosynthetic partners, green alga or cyanobacterium. Most species of fungi, including lichenized fungi, produce a plethora of secondary metabolites, which are species-specific nonessential metabolites that are highly diverse and have biological activity. These compounds provide unique functions that can aid organisms in niche-specific adaptations and can serve as defense against disease and predation.
Antibiotics such as penicillin, and cephalosporin are derived from fungi, and fungal derived antifungal griseofulvin is used to treat athlete's foot and toe-nail fungus. Other unique fungal metabolites used in medical applications include: cyclosporins (immunosuppressants), statins (cholesterol lowering drugs) and, fumagillin and pseurotin (angiogenesis inhibitors). One major group of agricultural fungicides, the strobilurins, was originally discovered in extracts of the fungus Strobilurus tenacellus.
The methods described herein can provide new types of compounds with useful activities. The inventors can use a unique MSU resource, the Lichen Herbarium, to identify novel compounds to develop into anti-fungal products for medicine and agriculture. The lichen collection in the Plant Biology Department at MSU, an NSF funded herbarium, houses more than 120,000 specimens and has the greatest taxonomic and geographical diversity among its collection compared to all other lichen herbaria in North America.
A variety of types of lichens can be used in the methods described herein and can be a source of useful compounds including, for example, crustose lichens, foliose lichens, leprose lichens, squamulose lichens, and fructose lichens.
Lichens have an algal species associated with a fungal species. Algal species associated with lichens are in the genera Nostoc, Trebouxia and Trentephlia, which comprise the algae in 90% of lichens. These algae can be found free living.
The variation in lichen morphology and physiology is dictated by the fungus. It is therefore most likely that compounds that are uniquely produced by a species of lichen are produced by the fungus.
In some cases, the lichen can include species of the genus Acarospora, Arctoparmelia, Amandinea, Aspicilia, Austroparmelina, Baeomyces, Biatorina, Buellia, Bryoria, Byssoloma, Calicium, Cladonia, Caloplaca, Candelariella, Cetraria, Cetrelia, Chrysothrix, Cladia, Cladonia, Coenogonium, Collema, Conotrema, Cryptothecia, Dendrographa, Dermatocarpon, Dictyonema, Diploicia, Diploschistes, Dirinaria, Endocarpon, Flavopanctelia, Flavoparmelia, Flavopunctelia, Fulgensia, Fuscopannaria, Graphina, Graphis, Graphis, Gyrophora, Haematomma, Heppia, Herpothallon, Herpothalon, Heterodea, Heterodermia, Hypocenomyce, Hypogymnia, Lasallia, Lecanora, Lecidea, Leioderma, Lepraria, Letharia, Leptogium, Lichen, Lecidea, Lichenomphalia, Lobaria, Menegazzia, Metus, Multiclavula, Myelorrhiza, Neophyllis, Nephroma, Niebla, Nostoc, Ochrolechia, Opegrapha, Opegrapha, Pannaria, Paraparmelia, Paraporpidia, Parmelia, Parmeliella, Parmeliopsis, Parmotrema, Peltigera, Peltigera, Peltula, Pertusaria, Pertusaria, Pertusaria, Pertusaria, Pertusaria, Phaeographina, Phaeophyscia, Phlyctis, Physcia, Physconia, Placidium, Placodium, Placopsis, Placopsis, Platismatia, Pseudephebe, Pseudevernia, Pseudocyphellaria, Pseudocyphellaria, Psora, Punctelia, Pyxine, Ramalina, Ramboldia, Relicina, Rhizocarpon, Rhizoplaca, Roccella, Sagedia, Siphula, Sporopodium, Stereocaulon, Sticta, Stictis, Strigula, Teloschistes, Tephromela, Thamnolia, Thysanothecium, Trapelia, Umbilicaria, Usnea, Xanthomaculina, Xanthopannelia, Xanthoria, or a combination thereof.
Examples of lichens that can be used include those of the type or species Acarospora citrina, Arctoparmelia centrifuga, Amandinea punctate, Aspicilia fruticulosa, Aspicilia fruticulosa, Aspicilia vagans, Aspicilia, Austroparmelina pruinata, Austroparmelina pseudorelicina, Baeomyces heteromorphus, Biatorina erysiboides, Bryoria fremontii, Buellia frigida, Buellia foecunda, Buellia grimmiae, Buellia subcoronata, Byssoloma, Calicium chrysocephalum, Caloplaca cinnabarina, Caloplaca cinnabarina, Caloplaca, Candelariella aurella, Cetraria islandica, Cetrelia olivetorum, Chrysothrix xanthine, Chrysothrix, Cladia aggregate, Cladia monilifonnis, Cladia retipora, Cladonia chlorophaceae, Cladonia crispate, Cladonia crispata, Cladonia cristatela, Cladonia didyma, Cladonia digitate, Cladonia fimbriate, Cladonia fimbriate, Cladonia mitis, Cladonia pyxidate, Cladonia pyxidate, Cladonia rangiferina, Cladonia stellaris, Cladonia sylvatica, Cladonia ustulata, Coenogonium implexum, Collema coccophorum, Conotrema urceolatum, Cryptothecia scripta, Dendrographa leucophaea, Dermatocarpon miniatum, Dictyonema sericeum, Diploicia canescens, Diploschistes thunbergianus, Dirinaria pieta, Endocarpon pusillum, Ephebe lanata, Evernia mesomorpha, Evernia prunastri, Flavopanctelia flaventior, Flavopanmelia caperata, Flavopanmelia rutidota, Flavopunctelia soredica, Fulgensia cranfieldii, Fuscopannaria leucosticte, Fuscopannaria leucosticte, Fuscopannaria subimmixta, Graphis bulacana, Graphina rubens, Graphis mucronate, Graphis treubii, Gyrophora murina, Haematomma africanum, Haematomma eremaeum, Heppia despreauxii, Herpothalon rubrocinctum, Heterodea beaugleholei, Heterodea muelleri, Heterodermia leucomelos, Hypocenomyce australis, Hypogymnia physodes, Hypogymnia pulverate, Lasallia papulose, Lasallia pustulata, Lecanora caesiorubella, Lecanora circumborensis, Lecanora conizaeoides, Lecanora epibryon, Lecanora pseudistera, Letharia vulpina, Letharia vulpine, Lecidea terrena, Leioderma pycnophorum, Lepraria lobiflcans, Lepraria lohiticans, Leptogium saturninum, Lichen caninus, Lichen ceuthocarpus, Lichen murorum, Lichen rufescens, Lichen sylvaticus, Lichenomphalia chromacea, Lecidea psora, Lobaria pulmonaria, Menegazzia platytrema, Metus conglomeratus, Multiclavula mucida, Myelorrhiza antrea, Neophyllis melacarpa, Nephroma arctica, Nephroma cellulosum, Niebla cephalota, Nostoc, Ochrolechia tartarea, Opegrapha varia, Opegrapha venosa, Parmelia sulcate, Parmeliella plumbea, Pannaria sphinctrina, Paraparmelia lithophiloides, Paraporpidia leptocarpa, Parmelia signifera, Parmeliopsis chlorolecanorica, Parmotrema perlatum, Peltigera canina, Peltigera trumlata, Peltula euploca, Parmelia sulcate, Pertusaria erebescens, Pertusaria pseudodactylina, Pertusaria subventosa, Pertusaria melaleucoides, Pertusaria novaezelandiae, Pertusaria, Phaeographina lamii, Phaeophyscia orbicularis, Phlyctis, Physcia aipolia, Physcia millegrana, Physconia deters, Physcia stellaris, Placidium squamulosum, Placodium murorum, Placopsis perrugosa, Placopsis, Platismatia glauca, Pseudephebe pubescens, Pseudevernia farinacea, Pseudevernia furfuracea, Pseudocyphellaria berberina, Pseudocyphellaria billardierei, Pseudocyphellaria crocata, Pseudocyphellaria freycinetii, Pseudocyphellaria gilva, Pseudocyphellaria norvegica, Pseudocyphellaria multiflda, Pseudocyphellaria gilva, Pseudocyphellaria, Psora crystallifera, Psora decipiens, Punctelia borreri, Punctelia subrudecta, Pyxine cocoes, Ramalina farinacea, Ramalina fastigiate, Ramalina fastigiate, Ramalina fraxinea, Ramalina menziesii, Ramalina siliquosa, Ramalina siliquosa, Caloplaca sp., Tephromela atra, Ramboldia petraeoides, Relicina gemmulosa, Rhizocarpon geographicum, Rhizocarpon geographicum, Rhizoplaca melanophthalma, Roccella canariensis, Roccella portentosa, Sagedia macrospora, Siphula coriacea, Sporopodium vezdeanum, Stereocaulon ramulosum, Stereocaulon saxatile, Sticta limbate, Stictis, Strigula smaragdula, Strigula subtilissima, Teloschistes, Tephromela atra, Thamnolia vermicularis, Thamnolia vermicularis, Thysanothecium scutellatum, Thysanothecium sorediatum, Trapelia crystallifera, Trapelia, Umbilicaria decussata, Umbilicaria hyperborean, Umbilicaria pustulata, Umbilicaria hyperborean, Usnea antarctica, Usnea arizonica, Usnea himantodes, Usnea inermis, Usnea rubicunda, Usnea scabrida, Usnea strigosa, Usnea strigose, Usnea subfloridana, Usnea wasmathii, Xanthomaculina convoluta, Xanthoparmelia amplexula, Xanthoparmelia arapilensis, Xanthoparmelia baeomycesica, Xanthoparmelia chlorochroa, Xanthoparmelia convolute, Xanthoparmelia cravenii, Xanthoparmelia ewersii, Xanthoparmelia mougeotina, Xanthoparmelia notata, Xanthoparmelia praegnans, Xanthoparmelia pseudoamphixantha, Xanthoparmelia pulla, Xanthoparmelia reptans, Xanthoparmelia semiviridis, Xanthoparmelia substrigosa, Xanthoparmelia taractica, Xanthoparmelia versicolor, Xanthoria fllsonii, Xanthoria hasseana, Xanthoria parietina, or a combination thereof. For example, any of the lichens listed in Appendix I of U.S. Provisional Application Ser. No. 62/702,424, filed Jul. 24, 2018 can be used in the methods described herein and can be a source of useful compounds.
In some cases, lichens such as Cladonia crispata, Cladonia cristatella, Cladonia digitate, Cetraria islandica, Cetrelia olivetorum, Cladonia sylvatica, Evernia prunastri, Hypogymnia physodes, Platismatia glauca, Pseudevernia furfuracea, Ramalina fastigiate, Ramalina fraxinea, Usnea strigosa, or a combination thereof can be extracted and/or can be a source of useful compounds.
Mycotoxin
As indicated above, the most serious mycotoxin may be aflatoxin in terms of contamination of crops. Aflatoxin is mainly produced by strains of Aspergillus flavus and Aspergillus parasiticus, which are ubiquitous in nature. Aspergillus flavus and Aspergillus parasiticus have no specificity towards their hosts and therefore can infect many different seeds of cereals, nut beans, coffee beans and oil-rich seeds during cultivation, harvest and post-harvest storage. These fungi infect crops such as maize and peanut and produce aflatoxin under the tropical and subtropical environments. Large amounts of aflatoxins can be produced, especially under humid storage conditions.
Deoxynivalenol is the most common trichothecene affecting agriculture production in the US, usually produced by Fusarium graminearum, and causing major losses in maize, wheat, barley and other small grains. The presence of rain during grain flowering encourages fungus dispersal and infection. Areas of the Midwest and the Red River Valley are particularly affected by the disease. The presence of the fungus greatly reduces grain yields, and a very small amount of fungal contamination renders barley unusable for malting.
Methods
The activities of lichen extracts were evaluated using experimental fungal organisms to ascertain whether the extracts could inhibit the growth or functions of the fungal organisms. In experiments described herein tested for their effects on sporulation, hyphal growth and mycotoxin production in the filamentous fungus Aspergillus parasiticus. For example, Aspergillus parasiticus is one of the main producers of aflatoxin.
Aspergillus parasiticus is useful for screening for antifungal activity. A. parasiticus is a plant pathogen, and produces the mycotoxin aflatoxin. It is extremely closely related to A. flavus, a human and plant pathogen, and A. fumigatus, a human pathogen. Vegetative growth allows fungi to colonize substrates, such as grain, and human tissues in the case of mycotic disease. Vegetative growth is associated with the production of toxins such as aflatoxin. Sporulation is important in dissemination of fungi in open air, agricultural fields, and in systemic spread through the human body. Small spores are easily carried in the bloodstream. Thus, compounds effective on A. parasiticus can be potentially used in medical, agricultural and food safety applications. A primary visual screen of growth, sporulation and secondary metabolism has been performed on lichen extracts using a mutant of A. parasiticus called B62 that accumulates norsolorinic acid, an orange-red precursor of aflatoxin (
Also as illustrated herein, Fusarium graminearum can be used in assays for screening lichen extracts for inhibiting deoxynivalenol production by the Fusarium species.
Lichen extracts can be prepared in a variety of ways. In some embodiments, lichen samples are dried (e.g. at room temperature in the dark). Samples can then be ground in a mill. Samples are then extracted with a solvent (e.g., an alcohol, ethyl acetate, or acetone). Solvents other than alcohols, ethyl acetate, and acetones were not as effective. The solvent employed for extraction can be methanol, ethanol, ethyl acetate, acetone, or a combination thereof.
In some embodiments, extracts are then filtered and dried. The resulting residue can be dissolved in a solvent (e.g., alcohol, ethyl acetate, acetone, water or a combination thereof) to yield a final suspension. In some embodiments, suspensions are generated with different concentrations of lichen material. In some embodiments, the extract preparation methods described in Examples 1-5 below are utilized.
In some embodiments, active ingredients (e.g., with anti-fungal activity or toxin inhibitory activity) are further purified. Purification methods are well known in the art and include, but are not limited to, extraction, fractionation, and chromatography. The presence of active ingredient is followed at each step of the process (e.g., using the activity assays described herein) and fractions with active ingredients are carried to the next step.
In some embodiments, purified active components are identified. Methods for identifying both small molecule and large molecule (e.g., protein) components are available and include, but are not limited to, high pressure liquid chromatography (HPLC), mass spectroscopy, nuclear magnetic resonance, and combinations thereof.
The experiments described herein illustrate that lichen extracts are useful as inhibitors of fungal growth and fungal functions. For example, several lichen extracts and pure lichen compounds exhibit inhibitory effects on aflatoxin production by Aspergillus parasiticus, when grown in culture or on corn kernels, as a model for field conditions. Specifically, pre-treatment of corn kernels with crude extracts of Cladonia cristatela, Pseudevernia furfuracea, Cetraria islandica, Cetrelia olivetorum, or Evernia prunastri inhibited aflatoxin BI accumulation when applied prior to inoculation with A. parasiticus. Extracts of C. cristatela showed significant inhibition of AFB I by 99%. Lecanoric acid, identified in the extract of Cetrelia olivetorum, and methyl-orsellinate, which is present in Physcia stellaris and Hypogymnia physodes, demonstrated inhibitory effects on growth and aflatoxin production in A. parasiticus culture.
Extracts of 70 lichen species were generated. Three of the seventy extracts inhibited Aspergillus parasiticus growth. Ten of the seventy extracts inhibited Aspergillus parasiticus sporulation. Fifty-nine of the lichen extracts inhibited secondary metabolite production, where aflatoxin was used as a proxy for secondary metabolite production. The most common activity observed for the lichen extracts across the phylogeny was therefore in arresting secondary metabolite production.
Extracts of two lichens were tested in cultures with Fusarium graminearum, using assay methods like those described for Aspergillus parasiticus. Treated cultures showed significant reduction in deoxynivalenol and 1-acetyldeoxynivalenol without significant effect on Fusarium graminearum growth.
Compositions Compositions described herein can include at least one lichen extract, extract component, or compound purified from a lichen extract. The compositions can also include additional components such as a carrier, solvent, surfactant, an additional active ingredient, or a combination thereof.
These compositions are useful as antibiotics and anti-fungal compositions.
The composition can contain varying amounts of the extract components, or compounds purified from the extracts described herein. For example, the extracts or compounds can be present in liquid compositions at concentrations of about 0.1 μg/mL to about 1000 μg/mL, or about 1 μg/mL to about 800 μg/mL, or about 3 μg/mL to about 600 μg/mL, or about 5 μg/mL to about 500 μg/mL, or about 5 μg/mL to about 300 μg/mL.
In dry compositions, the extracted components or compounds can be present in at weight/weight concentrations of about 0.1 μg/g to about 1000 μg/g, or about 1 μg/g to about 800 μg/g, or about 3 μg/g to about 600 μg/g, or about 5 μg/g to about 500 μg/g, or about 5 μg/g to about 300 μg/g.
The compositions can therefore be dry compositions or liquid compositions.
In some instances, the extracted components or compounds are dissolved in a solvent to form a liquid composition with a known concentration of at least one component or compound from an extract described herein. The solvent can be an alcohol, ethyl acetate, acetone, water, or a combination thereof. For example, the solvent can be ethanol, methanol, ethyl acetate, acetone, water, or a combination thereof.
The compositions can contain a carrier such as an emulsifier, a dispersing agent, thickening agent, a surfactant, a clay, a polymer, a colorant, a wetting agent of ionic or non-ionic type, a natural or regenerated mineral substance, a dispersant, a wetting agent, a tackifier, a thickener, a binder, or a mixture of such carriers. For example, the compositions can contain polyacrylic acid salts, lignosulphonic acid salts, phenolsulphonic or naphthalenesulphonic acid salts, polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines, substituted phenols (in particular alkylphenols or arylphenols), salts of sulphosuccinic acid esters, taurine derivatives (in particular alkyl taurates), phosphoric esters of polyoxyethylated alcohols or phenols, fatty acid esters of polyols, and derivatives of the present compounds containing sulfate, sulfonate and phosphate functions. The presence of at least one surfactant can be included when the active compound and/or the inert support are water-insoluble and when the vector agent for the application is water. For example, surfactant content can be about 5% to 40% by weight of the composition.
Coloring agents such as inorganic pigments can be present in the composition, for example iron oxide, titanium oxide, ferrocyan blue, and organic pigments such as alizarin, azo and metallophthalocyanine dyes, and trace elements such as iron, manganese, boron, copper, cobalt, molybdenum and zinc salts can be used. The compounds can be present in paints along with any available coloring material(s) and other components typically employed in paints.
Optionally, other additional components may also be included, e.g. protective colloids, adhesives, thickeners, thixotropic agents, penetration agents, stabilizers, sequestering agents.
The compositions can also include other ingredients. For example, bactericidal compounds can be employed. In addition, the compounds described herein can be used together in a composition or they can be used concomitantly with one or more of the other agrichemicals such as various pesticides, acaricides, nematicides, other types of fungicides, and plant growth regulators.
Various types of additional fungicides can optionally be included in the compositions described herein. Examples include copper fungicide such as basic copper chloride and basic copper sulfate, sulfur fungicide such as thiuram, zineb, maneb, mancozeb, ziram, propineb, and polycarbamate, polyhaloalkylthio fungicide such as captan, folpet, dichlorfluanid, organochlorine fungicide such as chlorothalonil, fthalide, organophosphorous fungicide such as O,O-bis(1-methylethyl) S-phenylmethyl phosphorothioate (IBP), edifenphos (EDDP), tolclophos-methyl, pyrazophos, fosetyl, dicarboxylmide fungicide such as iprodione, procymidone, vinclozolin, fluoromide, carboxyamide fungicide such as oxycarboxin, mepronil, flutolanil, tecloftalam, trichlamide, pencycuron, acylalanine fungicide such as metalaxyl, oxadixyl, furalaxyl, methoxyacrylate fungicides such as kresoxim-methyl (stroby), azoxystrobin, metominostrobin, trifloxystrobin, pyraclostrobin, anilinopyrimidine fungicide such as andupurine, mepanipyrim, pyrimethanil, cyprodinil, antibiotic agents such as polyoxin, blasticidin S, kasugamycin, validamycine, dihydrostreptomycin sulfate, propamocarb hydrochloride, quintozene, hydroxyisoxazole, methasulfocarb, anilazine, isoprothiolane, probenazole, chinomethionat, dithianon, dinocap, diclomezine, ferimzone, fluazinam, pyroquilon, tricyclazole, oxolinic acid, iminoctadine acetate, iminoctadine albesilate, cymoxanil, pyrrolnitrin, diethofencarb, binapacryl, lecithin, sodium bicarbonate, fenaminosulf, dodine, dimethomorph, phenazine oxide, carpropamide, flusulfamide, fludioxonil, famoxadone, or combinations thereof. Hence, other types of fungicides can be mixed together with and used in various amounts with one or more of the extracts or compounds described herein.
The extracts, extract components, and compounds described herein can be used in a weight ratio relative to the other type of fungicide such as from 1:0.001 to 1:1000 as a weight ratio. In some instance, the amount of an extract, extract component, or compound purified from a lichen extract relative to the other type of fungicide can vary from 1:0.01 to 1:100 as a weight ratio within a composition.
Pesticides can be included in the compositions, with any of the compounds described herein. The pesticides can include organophosphorous pesticides, carbamate pesticides such as fenthion, fenitrothion, diazinon, chlorpyrifos, ESP, vamidothion, phenthoate, dimethoate, formothion, malathon, trichlorfon, thiometon, phosmet, dichlorvos, acephate, EPBP, methylparathion, oxydemeton-methyl, ethion, salithion, cyanophos, isoxathion, pyridaphenthion, phosalone, methidathion, sulprofos, chlorfevinphos, tetrachlorvinphos, dimethylvinphos, propaphos, isofenphos, ethylthiometon, profenofos, pyraclofos, monocrotophos, azinphosmethyl, aldicarb, methomyl, thiodicarb, carbofuran, carbosulfan, benfuracarb, furathiocarb, propoxur, BPMC, MTMC, MIPC, carbaryl, pirimicarb, ethiofencarb, and fenoxycarb, pyrethroid pesticides such as permethrin, cypermethrin, deltamethrin, fenvalerate, fenpropathrin, pyrethrin, allethrin, tetramethrin, resmethrin, dimethrin, propathrin, phenothrin, prothrin, fluvalinate, cyfluthrin, cyhalothrin, flucythrinate, ethofenprox, cycloprothrin, tralomethrin, silafluofen, brofenprox, and acrinathrin, and benzoylurea and other types of pesticides such as diflubenzuron, chlorfluazuron, hexaflumuron, triflumuron, tetrabenzuron, flufenoxuron, flucycloxuron, buprofezin, pyriproxyfen, methoprene, benzoepin, diafenthiuron, acetamiprid, imidacloprid, nitenpyram, fipronil, cartap, thiocyclam, bensultap, nicotin sulfate, rotenone, mataldehyde, machine oil, and microbial pesticides e.g. BT and insect pathogenic virus.
Acricides can be included in the compositions described herein. The acricides that can be employed include, for example, chlorbenzilate, phenisobromolate, dicofol, amitraz, BPPS, benzomate, hexythiazox, fenbutatin oxide, polynactin, chinomethionat, CPCBS, tetradifon, avermectin, milbemectin, clofentezin, cyhexatin, pyridaben, fenpyroximate, tebufenpyrad, pylidimifen, fenothiocarb, and dienochlor.
As for the aforementioned nematicides, fenamiphos, fosthiazate and the like can be specifically exemplified; as for plant-growth regulators, gibberellins (e.g., gibberellin A3, gibberellin A4, and gibberellin A7), auxin, 1-naphthaleneacetic acid, and so on can be specifically exemplified.
More generally, the active compounds can be combined with any solid or liquid additive, which complies with the usual formulation techniques. In general, the composition according to the invention may contain from 0.05 to 99% by weight of active compounds, preferably from 10 to 70% by weight.
The extracts, extract component, extracted compounds or compositions can be provided in a form that is ready-to-use or in a form that can be prepared for use. The extracts, extract component, extracted compounds, or compositions can be applied by a suitable device, such by use of a spraying or dusting device. The extracts, extract component, extracted compounds, or compositions can be applied by use of brush or roller.
The extracts, extract component, extracted compounds, or compositions can be provided in concentrated commercial compositions that should be diluted before application to the crop. For example, the extracts, extract component, extracted compounds, or compositions can be provided in dry (e.g., lyophilized) form, or in concentrated form, and then dissolved or diluted as desired. The compositions can be in formulated into an aerosol dispenser, as a capsule suspension, as a cold fogging concentrate, as a dustable powder, as an emulsifiable concentrate, as an emulsion oil in water, as an emulsion water in oil, as an encapsulated granule, as a fine granule, as a flowable concentrate for seed or nut treatment, as a gas (under pressure), as a gas generating product, as granules, as a hot fogging concentrate, as macrogranules, as microgranules, as an oil dispersible powder, as an oil miscible flowable concentrate, as an oil miscible liquid, as a paste, as a plant rodlet, as a powder for dry seed or nut treatment, as seeds or nuts coated with the composition, as a soluble concentrate, as a soluble powder, as a solution for seed (or other) treatment, as a suspension concentrate (flowable concentrate), as an ultra-low volume (ULV) liquid, as an ultra-low volume (ULV) suspension, as water dispersible granules or tablets, as a water dispersible powder for slurry treatment, as water soluble granules or tablets, as a water soluble powder for seed or nut treatment, as a wettable powder, or as a combination thereof (e.g., two types of formulations packaged together).
The following Examples illustrate some of the experimental work involved in the development of the invention.
This Example describes materials and methods for extraction of lichens. Lichens were collected fresh, and in some cases herbarium specimens were surveyed, where the oldest herbarium specimen dated back to 1949. Extracts were done in methanol, ethanol, ethyl acetate, and acetone; other solvents did not appear to extract activities as well. Activities were found to be quite stable in herbarium specimens, even amongst the oldest specimens.
A primary visual screen of growth, sporulation and secondary metabolism was performed on lichen extracts using a mutant of Aspergillus parasiticus strain B62 which accumulates norsolorinic acid (NA), an orange-red precursor of aflatoxin. Norsolorinic acid quantification was performed by use of a chromameter. Use of this species for initial screens has facilitated fast identification of activities.
Extracts of two lichens were tested in cultures with Fusarium graminearum, using methods like the assay methods used for Aspergillus parasiticus. Aspergillus parasiticus was grown on glucose mineral salts (GMS) medium. Fusarium graminearum was grown on High DON Medium from Linda Harris (McCormick et al., Appl. Environ. Microbiol. 70:2044-2051 (2004)).
A set of high-throughput screens for discovery of antifungal agents were developed using spices as a potential source of inhibitors of mycotoxin biosynthesis. Black pepper extracts were used in an initial screen.
Extracts of spices were added to Aspergillus parasiticus B62 cultures in GMS, YES, and PMS media (Buchanan & Lewis (1984)) as described in Annis et al. (2000). Changes in growth, sporulation and mycotoxin production were observed. Extracts with promising effects were screened using the Thin Layer Chromatography (TLC) bioassay developed by the inventors and coworkers (Annis et al., 2000; Trail et al. 2006). This technique resulted in the identification of a novel activity in black pepper that turned off genes for aflatoxin production but did not arrest fungal growth. Based on HPLC, and MS analysis, putative structures were synthesized and two active structures have been identified. One structure inhibits aflatoxin biosynthesis but does not affect fungal growth, the other inhibits fungal growth.
In preliminary studies, extracts from four lichen species were tested for effects on growth, sporulation and mycotoxin biosynthesis in A. parasiticus (
High through-put assays were performed in 24 well plates to evaluate the antifungal effects of lichen extracts on the fungal Aspergillus parasiticus strain B62. An orange-red pigment was a precursor and indicator of aflatoxin production.
Table 1 shows results of assays for inhibition of growth, aflatoxin production, and sporulation of Aspergillus parasiticus B62 by extracts of the indicated lichen species are shown. The growth, aflatoxin production, and sporulation of Aspergillus parasiticus B62 was compared to Control. The symbols used in Table 1 were: N—No effect; SI—Strong Inhibition (90-100%); I—Inhibition (38-80%); A—Activation (˜150%); SA—Strong Activation (>150%).
Bryoria fremontii
Cetraria islandica
Cetrelia olivetorum
Cetrelia sp CA Bay Area
Cladonia chlorophaceae
Cladonia crispata
Cladonia cristatela (British soldier)
Cladonia didyma +
Cladonia fimbriata
Cladonia digitata
Cladonia mitis
Cladonia pyxidata (Owen)
Cladonia rangiferina
Cladonia stellaris
Cladonia sylvatica
Dendrographa leucophaea
Dermatocarpon miniatum
Ephebe lanata
Evernia mesomorpha
Evernia prunastri
Flavopanctelia flaventior
Flavoparmelia caperata
Flavopunctelia soredica
Fuscopannaria leucosticta
Graphis bulacana
Herpothalon rubrocinctum 2016
Hypogymnia physodes
Lecanora caesiorubella
Lecanora circumborensis
Lecidea psora
Lepraria lohiticans
Leptogium saturninum
Letharia vulpina,
Lobaria pulmonaria
Nephroma arctica
Niebla cephalota
Parmelia sulcata +
Flavoparmelia caperata
Parmeliella plumbea
Peltigera canina
Peltigera trumlata AF10981
Peltula euploca
Pertusaria erebescens
Phaeophyscia orbicularis, Alan
Physcia aipolia Memos 2014
Physcia millegrana
Physcia stellaris
Physconia deters
Pseudevernia farinacea
Pseudevernia furfuracea
Pseudocyphellaria berberina
Pseudocyphellaria crocata
Pseudocyphellaria freycinetii
Psendocyphellaria gilva, AF 10877
Pseudocyphellaria norvegica
Ramalina farinacea
Romalina fastigiata
Ramalina fraxinea Latvia May 2016
Romalina menziesii Asilomar 2015
Rhizoplaca melanophthalma
Roccella portentosa
Stereocaulon saxatile
Thamnolia vermicularis
Umbilicaria hyperborea +
Pseudephebe
pubescens
Usnea arizonica
Usnea rubicunda
Usnea strigosa
Usnea subfloridana
Usnea wasmathii
Xanthoparmelia chlorochroa
Xanthoria hasseana
Xanthoria parietina
This Example illustrates that extracts of Cladonia cristatella inhibits secondary metabolite production by Aspergillus parasiticus strain B62.
Ascospores from Cladonia cristatella were isolated and cultured as illustrated in
This Example illustrates that extracts of Evernia prunastri inhibit hyphal growth, secondary metabolite production, and sporulation by Aspergillus parasiticus strain B62.
Extracts of Evernia prunastri were cultured with Aspergillus parasiticus B62 in GMS (Buchanan & Lewis, 1984). As illustrated in
The following lichen extracts were tested for their capacity to reduce aflatoxin accumulation in corn kernels.
Extracts of lichens #1, 99 and 101 demonstrated protective effects against aflatoxin contamination, showing 80-70% inhibition of aflatoxin accumulation on DeDell field corn kernels (200 spores/kernel, 96 h post inoculation). Extracts obtained from lichen #81 inhibited aflatoxin B1 accumulation by 99% on sweet corn kernels. The extract from #129 was active on Monsanto field corn kernels after 72 h post inoculation. All of these represent statistically significant findings.
Chemicals preserved in dry lichens appear to be largely stable under standard herbarium storage conditions. Thin layer chromatography (TLC) analyses of acetone extracts from the identical lichen specimens obtained eight years apart demonstrated similar metabolite profiles (
Extracts of two lichens, Evernia pruastris and Hypogymnia physodes, were tested in cultures with Fusarium graminearum, using assay methods like those used for the assays of Aspergillus parasiticus.
As illustrated in
The fungus Fusarium graminearum is a plant pathogen which causes fusarium head blight, a devastating disease on wheat and barley. This Example illustrates that extracts from various lichens can reduce deoxynivalenol (DON) production by Fusarium graminearum.
In a first experiment, Fusarium graminearum cultures were grown in 24-well plates for 6 days in the dark at room temperature. Each well contained 1 ml High DON Medium (McCormick et al., 2004) plus 20 μl of lichen extract (either Evernia pruastris [number 1] or Hypogymnia physodes [number 57]), while control wells contained 20 μl ethanol without a lichen extract. Cultures exhibiting decreased production of red/pink pigment but no effects on growth were analyzed for DON accumulation.
In a second experiment, Fusarium graminearum cultures were grown in 24-well plates for 6 days in the dark at room temperature. Each well contained 1 ml High DON Medium plus 20 μl of a lichen extract from Cladonia sylvatica [15], Usnea strigosa [33], Cladonia digitate [58], Ramalina fastigiate [62], Ramalina fraxinea [98], Platismatica glauca [100], Evernia prunastri [112], or Cladonia crispata [118]. Control wells contained 20 μl acetone without any lichen extract. Cultures exhibiting decreased production of red/pink pigment but no effects on growth were analyzed for DON accumulation.
As shown in
This Example described results of assaying various lichens that had been stored for extended periods of time to determine if they could still inhibit growth, norsolorinic acid (NA) production, and sporulation by Aspergillus parasiticus.
Lichens were obtained after storage under herbarium storage conditions, extracts were made, and the extracts were added to Aspergillus parasiticus cultures. This assessment of lichen extract activity was performed in 2014-2015.
Table 2 shows which lichens were evaluated, and whether the Aspergillus parasiticus grew, accumulated norsolorinic acid, and sporulated (N indicates that no growth, no NA, or no sporulation was observed).
Stereolaulon saxatile,
Petula euploca,
Graphis bulacana,
Ephebe lanata, Flora
Lecidea psora,
Activity of assay was performed in 2014-2015. N, no effect.
As illustrated, each of the lichens shown in Table 2 inhibited 90-100% of norsolorinic acid accumulation even though the lichens had been stored since 1949-1963.
All patents and publications referenced or mentioned herein are indicative of the levels of skill of those skilled in the art to which the invention pertains, and each such referenced patent or publication is hereby specifically incorporated by reference to the same extent as if it had been incorporated by reference in its entirety individually or set forth herein in its entirety. Applicants reserve the right to physically incorporate into this specification any and all materials and information from any such cited patents or publications.
The following statements describe some of the elements or features of the invention. Because this application is a provisional application, these statements may become changed upon preparation and filing of a nonprovisional application. Such changes are not intended to affect the scope of equivalents according to the claims issuing from the nonprovisional application, if such changes occur. According to 35 U.S.C. § 111(b), claims are not required for a provisional application. Consequently, the statements of the invention cannot be interpreted to be claims pursuant to 35 U.S.C. § 112.
Statements:
This application is a continuation of U.S. application Ser. No. 16/521,326, filed Jul. 24, 2019, which claims benefit of priority to the filing date of U.S. Provisional Application Ser. No. 62/702,424, filed Jul. 24, 2018, the contents of which are specifically incorporated herein by reference in their entity.
Number | Name | Date | Kind |
---|---|---|---|
20090048332 | Choudhary | Feb 2009 | A1 |
20200029575 | Trail et al. | Jan 2020 | A1 |
Entry |
---|
“U.S. Appl. No. 16/521,326, Advisory Action dated Mar. 12, 2021”, 3 pgs. |
“U.S. Appl. No. 16/521,326, Examiner Interview Summary dated Oct. 20, 2020”, 3 pgs. |
“U.S. Appl. No. 16/521,326, Final Office Action dated Jan. 4, 2021”, 10 pgs. |
“U.S. Appl. No. 16/521,326, Final Office Action dated Sep. 20, 2021”, 11 pgs. |
“U.S. Appl. No. 16/521,326, Non Final Office Action dated Apr. 20, 2021”, 9 pgs. |
“U.S. Appl. No. 16/521,326, Non Final Office Action dated Jul. 8, 2020”, 12 pgs. |
“U.S. Appl. No. 16/521,326, Response filed Mar. 4, 2021 to Final Office Action dated Jan. 4, 2021”, 9 pgs. |
“U.S. Appl. No. 16/521,326, Response filed May 15, 2020 to Restriction Requirement dated Mar. 19, 2020”, 7 pgs. |
“U.S. Appl. No. 16/521,326, Response filed Jul. 20, 2021 to Non Final Office Action dated Apr. 20, 2021”, 10 pgs. |
“U.S. Appl. No. 16/521,326, Response filed Nov. 4, 2020 to Non Final Office Action dated Jul. 8, 2020”, 10 pgs. |
“U.S. Appl. No. 16/521,326, Restriction Requirement dated Mar. 19, 2020”, 7 pgs. |
Dulger, et al., “”, Tr. J. of Biology vol. 22, (1998), 111-118. |
Kosanic, et al., “”, Pak. J. Pharm. Sci., vol. 24, No. 2, (2011), 165-170. |
Litvinov, et al., “Batanicheski Zhurnal”, Sankt-Peterburg, Russian Federation vol. 43, (1958), 557-560. |
Ristic, et al., “Current Pharmaceutical Biotechnology”, vol. 17, (2016), 1-8. |
Shrestha, et al., “”, Phytotherapy Research vol. 29, (2015), 100-107. |
Solhaug, et al., “”, Oecologia vol. 108, (1996), 412-418. |
Number | Date | Country | |
---|---|---|---|
20220104501 A1 | Apr 2022 | US |
Number | Date | Country | |
---|---|---|---|
62702424 | Jul 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16521326 | Jul 2019 | US |
Child | 17555057 | US |